Pfizer Buy, Sell, Hold: 2026 Stock Outlook and Strategy
Pfizer faced a post-pandemic revenue shift, but the 2026 landscape still offers income and defensive upside. This gui...
Investors follow market indices to gauge performance, set expectations, and benchmark risk. Indices provide a common frame for evaluating results.
28,426 articlesPfizer faced a post-pandemic revenue shift, but the 2026 landscape still offers income and defensive upside. This gui...
As AI workloads spur hyperscale data-center expansion, Vertiv’s order book signals a durable cycle that could lift th...
A lithium-focused startup has joined the unicorn club after a surge in demand for EV batteries. The move signals a br...
Anthropic operates under a rare governance structure: Dario Amodei oversees the company with a single direct report, ...
Air Lease stock posted a sharp 43% rally, yet a lease stock investor trims a sizable stake. This article breaks down ...
February delivered a sharp move for Iren Limited as the market wrestled with a bold pivot from neocloud mining to AI ...
U.S.-Israel strikes on Iran trigger sharp market moves as Trump calls regime change, raising the stakes for investors...
SpaceX is positioning Starship V3 as the backbone of an IPO that could redefine private markets. Analysts say the nex...
A closer look at dividend aristocrats with multi-decade payout streaks and what their steady income track means for i...
Broadcom posted solid revenue growth and a solid EPS beat, but AI chip guidance disappointed some. This guide breaks ...
Santander sinks 12.6% as unconfirmed trade news swirls around US-Spain tensions, but the bank’s 2025 profits and effi...
Three international dividend ETFs are delivering higher yields than SCHD in 2026, signaling a shift in income-focused...